Konstantin Konstantinov

Insider Reports History

Entity
Individual
Location
C/O Codiak Biosciences, Inc., 500 Technology Square, 9 Th Floor, Cambridge, MA
Signature
/s/ Kimberly Brown (Attorney in Fact)
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Konstantin Konstantinov:

Stock Role Class Num Shares Value Price $ Report Date Ownership
REPLIGEN CORP Director Common Stock 1.92K $314K $163.34 May 16, 2024 Direct
REPLIGEN CORP Director Stock Option (Right to Buy) 1.38K May 16, 2024 Direct
Codiak BioSciences, Inc. Chief Technology Officer Common Stock 0 Mar 28, 2023 Direct

Insider Reports Filed by Konstantin Konstantinov

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RGEN REPLIGEN CORP May 16, 2024 2 $0 4 May 20, 2024 Director
RGEN REPLIGEN CORP May 18, 2023 2 $0 4 May 22, 2023 Director
CDAKQ Codiak BioSciences, Inc. Mar 28, 2023 2 -$1.87K 4 Mar 30, 2023 Chief Technology Officer
CDAKQ Codiak BioSciences, Inc. Jan 24, 2023 1 $0 4 Jan 26, 2023 Chief Technology Officer
CDAKQ Codiak BioSciences, Inc. Jan 19, 2023 3 -$615 4 Jan 23, 2023 Chief Technology Officer
CDAKQ Codiak BioSciences, Inc. Sep 16, 2022 1 $0 4 Sep 20, 2022 Chief Technology Officer
CDAKQ Codiak BioSciences, Inc. Aug 16, 2022 6 -$3.72K 4 Feb 21, 2023 Chief Technology Officer
RGEN REPLIGEN CORP May 26, 2022 3 $0 4 May 31, 2022 Director
RGEN REPLIGEN CORP May 26, 2022 0 $0 3 May 31, 2022 Director
CDAKQ Codiak BioSciences, Inc. Feb 16, 2022 2 $0 4 Feb 18, 2022 Chief Technology Officer
CDAKQ Codiak BioSciences, Inc. Jan 19, 2022 2 $0 4 Jan 21, 2022 Chief Technology Officer
CDAKQ Codiak BioSciences, Inc. Jun 8, 2021 4 -$162K 4 Sep 28, 2021 Chief Technology Officer